Skip to main content
  • Investors
  • Mediaopen in a new window
  • Contact Usopen in a new window
  • |
Ironwood Logoopen in a new window
  • Company
  • Science & Medicine
  • Patients
  • Responsibility
  • Careers
  • IR Home
  • Why Invest
  • Events & Presentations
  • Corporate Governance
    • Governance Documents
    • Executive Management
    • Board of Directors
    • Committee Composition
    • Contact the Board
  • Financials
    • Quarterly Results
    • Annual Reports
    • SEC Filings
  • Press Releases
  • Investor Contacts
    • Investor Emails Alerts
    • RSS Feeds
  • Stock Information
    • Stock Quote & Chart
    • Historical Stock Quote
    • Analyst Coverage
    • Investor FAQs
  • IR Home
  • Why Invest
  • Events & Presentations
  • Corporate Governance
    • Governance Documents
    • Executive Management
    • Board of Directors
    • Committee Composition
    • Contact the Board
  • Financials
    • Quarterly Results
    • Annual Reports
    • SEC Filings
  • Press Releases
  • Investor Contacts
    • Investor Emails Alerts
    • RSS Feeds
  • Stock Information
    • Stock Quote & Chart
    • Historical Stock Quote
    • Analyst Coverage
    • Investor FAQs
Close
Close
  • Investors
  • Company
  • Product
  • Research & Development
  • Patients
  • Partnerships
  • Careers
Close

Press Releases

Normal
Press Release RSS Feed (opens in new window)
Press release year list 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
December 17, 2012
Ironwood and Forest Announce U.S. Availability of LINZESS™ (Linaclotide)
Download PDF format download (opens in new window)
December 6, 2012
Protagonist and Ironwood Expand Peptide Drug Discovery Collaboration
Download PDF format download (opens in new window)
November 28, 2012
Constella® (linaclotide) Approved in Europe for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C) in Adults
Download PDF format download (opens in new window)
November 9, 2012
Ironwood Pharmaceuticals to Present at the Credit Suisse 2012 Healthcare Conference
Download PDF format download (opens in new window)
November 1, 2012
Ironwood Pharmaceuticals to Host Webinar on Accounting Treatment for LINZESS™ (Linaclotide)
Download PDF format download (opens in new window)
October 23, 2012
Ironwood and AstraZeneca Announce Linaclotide Collaboration for China
Download PDF format download (opens in new window)
October 16, 2012
Ironwood Pharmaceuticals Provides Third Quarter 2012 Investor Update
Download PDF format download (opens in new window)
October 9, 2012
Ironwood Pharmaceuticals to Host Third Quarter 2012 Investor Update Call
Download PDF format download (opens in new window)
September 21, 2012
Linaclotide Receives Positive CHMP Opinion for the Treatment of IBS-C
Download PDF format download (opens in new window)
September 12, 2012
Ironwood Pharmaceuticals to Present at the UBS Global Life Sciences Conference
Download PDF format download (opens in new window)
September 6, 2012
Ironwood Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference
Download PDF format download (opens in new window)
August 30, 2012
Ironwood and Forest to Host Conference Call to Discuss FDA Approval of LINZESS™ (Linaclotide) for the Treatment of Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation
Download PDF format download (opens in new window)
August 30, 2012
Ironwood and Forest Announce FDA Approval of LINZESS™ (Linaclotide) for the Treatment of Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation
Download PDF format download (opens in new window)
July 17, 2012
Ironwood Pharmaceuticals Provides Second Quarter 2012 Investor Update
Download PDF format download (opens in new window)
July 10, 2012
Ironwood Pharmaceuticals to Host Second Quarter 2012 Investor Update Call
May 29, 2012
Ironwood Pharmaceuticals to Present at Upcoming Investor Conferences
May 14, 2012
Ironwood and Forest to Present 17 Linaclotide-Related Abstracts at Digestive Disease Week® 2012
May 8, 2012
Ironwood Pharmaceuticals to Present at Bank of America Merrill Lynch 2012 Health Care Conference
Download PDF format download (opens in new window)
May 1, 2012
Ironwood Pharmaceuticals Provides First Quarter 2012 Investor Update
Download PDF format download (opens in new window)
April 24, 2012
Ironwood Pharmaceuticals to Host First Quarter 2012 Investor Update Call
Download PDF format download (opens in new window)
April 23, 2012
Ironwood and Forest Announce FDA Has Extended the Review Period for Linaclotide to September 2012
Download PDF format download (opens in new window)
February 28, 2012
Ironwood Pharmaceuticals Provides Fourth Quarter 2011 Investor Update
Download PDF format download (opens in new window)
February 27, 2012
Ironwood Pharmaceuticals to Present at Cowen and Company Annual Health Care Conference
Download PDF format download (opens in new window)
February 21, 2012
Ironwood Pharmaceuticals to Host Fourth Quarter 2011 Investor Update Call
Download PDF format download (opens in new window)
February 13, 2012
Ironwood Pharmaceuticals Announces Exercise of Over-Allotment Option in Public Offering of Common Stock
Download PDF format download (opens in new window)
February 9, 2012
Ironwood Pharmaceuticals Prices Public Offering of Common Stock
Download PDF format download (opens in new window)
February 8, 2012
Ironwood Announces FDA Advisory Committee Meeting Will Not Be Scheduled in Connection with New Drug Application for Linaclotide
Download PDF format download (opens in new window)
February 8, 2012
Ironwood Pharmaceuticals Announces Proposed Public Offering of Common Stock
Download PDF format download (opens in new window)
January 4, 2012
Ironwood Pharmaceuticals and Bionomics Announce Collaboration, Research, and License Agreement
Download PDF format download (opens in new window)
January 3, 2012
Ironwood Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
Download PDF format download (opens in new window)

Investor Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Ironwood Pharmaceuticals, Inc., we strive to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Ironwood Pharmaceuticals, Inc. to send you the requested Investor Email Alert updates.

* Required

*
*





Email Alert Sign Up Confirmation

Ironwood Logoopen in a new window
  • Investors
  • Media
  • Contact us
Follow us on Linkedin Follow us on Twitter
  • COMPANY
  • Company Overview
  • Leadership
  • Open Payments & Transparecy
  • SCIENCE & MEDICINE
  • Therapeutic Focus
  • Pipeline
  • Product
  • PATIENTS
  • Overview
  • RESPONSIBILITY
  • Overview
  • Diversity, Equity & Inclusion
  • Sustainability
  • Safety & Compliance
  • Patients & Research
  • Community Giving
  • CAREERS
  • Working at Ironwood
  • Internships, Co-ops & Fellowships
  • Open Positions
  • Copyright © Ironwood. All rights reserved Powered By Q4 Inc. 5.77.0.2 (opens in new window)
  • Privacy Policy
  • California Privacy Policy
  • Site Map
  • Terms of Use